??GenScript’s global initiative is back, supporting groundbreaking work ???? ???????? ?????? ???????? ??????????????, ???????????????? ???????? ??????????????????, ???? ???????? ??????????????????, ?????????????? ??????????????????????, ?????? ??????????????????????. Partner with us and access comprehensive, reliable reagents and services to elevate your research. ??Over 50 grants will be awarded in two cycles throughout 2025, with funding up to $100,000 USD for qualifying projects. ??The first cycle ends on ???????? ???????? – don’t miss out! ??Learn more & submit your application today! https://bit.ly/4blXCwT #ResearchFunding #CellAndGeneTherapy #AntibodyDrugDiscovery #Vaccines #Diagnostics #LifeScience #HealthResearch #GrantOpportunities
GenScript
生物技术研究
Piscataway,NJ 174,539 位关注者
Make People and Nature Healthier through Biotechnology
关于我们
Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in healthcare and consumer goods by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to make people and nature healthier through biotechnology, and its role as a trusted global leader, GenScript has a team of over 5,000 employees and has served more than 200,000 customers across 100 countries.
- 网站
-
https://www.genscript.com/
GenScript的外部链接
- 所属行业
- 生物技术研究
- 规模
- 5,001-10,000 人
- 总部
- Piscataway,NJ
- 类型
- 上市公司
- 创立
- 2002
- 领域
- Gene synthesis、Peptide synthesis、Protein expression、Antibody services、Drug discovery services、Industrial synthetic biology products、gene editing、genome editing、gene therapy 、cell therapy和cancer research
地点
-
主要
860 Centennial Ave
US,NJ,Piscataway,08854
GenScript员工
动态
-
?? Unlock the secrets of antibody glycosylation and its critical role in enhancing therapeutic efficacy. Dive into the latest innovations in glycoengineering that are set to transform antibody-based treatments. ?? GenScript's TurboCHO?: From gene to antibody in just 5 business days, with a capacity of over 30,000 targets per month. Providing high-quality, cost-effective, and time-efficient solutions for all stages of antibody research, accelerating your scientific breakthroughs! ??Read more: https://bit.ly/3F1sO8z #Antibody #Biotech #GenScript #ScientificDiscovery #AntibodyGlycosylation #AntibodyEngineering
-
-
??Outstanding Application Data for Our Anti-Flag Resins: High Purity, Sensitivity, and Binding Capacity! GenScript offers various types of anti-DYKDDDDK (anti-flag) resins for purification and IP. ?? High Purity: >95% under different expression system ?? High Sensitivity: Capable of binding as low as 5 ng of protein ?? High Binding Capacity: >1.0 mg/ml resin Explore more: https://bit.ly/4bjta6t #antiflag #resin #proteinexpression #GenScriptproducts
-
-
?? ???????????????? ?????????????????? #??: Cracking the Code of DNA Replication ?? A groundbreaking study has uncovered how MCM2-7 ring closure, driven by the Mcm5 C-terminus, plays a critical role in DNA replication. This process not only ensures helicase loading at replication origins but also triggers Mcm4 ATP hydrolysis, setting off a cascade of molecular events essential for genome stability. ??????????????????'?? ????????????????????????: Providing custom-generated mutant MCM2-7 constructs, enabling researchers to pinpoint the essential role of the Mcm5 C-terminus in pre-RC formation. Another step forward in decoding the mechanics of DNA replication! ?? ?? Read the full study: "MCM2-7 Ring Closure Involves the Mcm5 C-Terminus and Triggers Mcm4 ATP Hydrolysis" - https://lnkd.in/eEdRSJCk ?? See how GenScript can support ???????? research: https://bit.ly/39GD9UH #GenScript #DNAReplication #Biotech #GenScriptCitations #GenomeStability #BiotechInnovation
-
?? Huge congratulations to @EvolutionaryScale for being published and landing the cover of the latest Science Magazine! Their groundbreaking AI model, ESM3, is a generative language model that reasons protein sequence, structure, and function, pushing the boundaries of natural evolution. In this paper, ESM3 was prompted to uncover a novel green fluorescent protein (GFP). It’s estimated this is equivalent to simulating five hundred million years of evolution! ??At GenScript, we're proud to have contributed to this remarkable achievement by providing our E.coli protein high-throughput expression capability. We understand the crucial role that CROs play in this new AI-driven world and are thrilled to extend our wet lab capabilities to support pioneering AI research. ??Discover how GenScript can accelerate your AI endeavors. Cell-Free Protein Service: https://bit.ly/3EZRUEP High throughput Enzyme Engineering: https://bit.ly/3EWy9Ov ??Let's make groundbreaking discoveries happen together! #AI #ProteinScience #Innovation #GenScript #ScienceMagazine #CRO
-
-
?? ???????? ???????? ?????? ?????????????????? ???? ???????????? ??????????????????????????! ??Are you ready to explore how neoantigens are revolutionizing cancer treatment? Our latest article delves into the clinical applications of neoantigens and highlights their potential in personalized cancer therapies. ??Recent breakthroughs in neoantigen discovery and their applications in personalized cancer vaccines and adoptive cell therapies pave the way for more effective treatments. ?Studies have shown that neoantigen-based approaches can elicit robust immune responses, leading to tumor regression in various malignancies. ??GenScript's innovative one-stop solutions for neoantigen peptide synthesis streamline your research and enhance your capabilities to develop targeted therapies. ??Discover how GenScript can help you accelerate your projects and drive breakthroughs in cancer immunotherapy. ?? Read the full article here: https://bit.ly/4h2z78Z Let’s push the boundaries of science together! #CancerResearch #Neoantigens #Immunotherapy #Biotech #GenScript #PersonalizedMedicine
-
-
?????????? ?????? ???????????????????? ?????????????????? ?????????????? ?????????????? ???????? ?????? ???????? ?????????????????? ?? Gain insight from leaders in the field of cell and gene therapy! Catch up on the many ways the FDA is advancing therapies while prioritizing safety and accessibility. ?????? ???????????????????? ??????????????: ?????????????????? ???????????? ???? ???????????? ??????????????????: The FDA’s Boxed Warning for CAR-T therapy reflects an evolving understanding of the risk of secondary malignancies. Refinement of messaging is planned to ensure innovation in the field. ???????????????????????????? ??????????????????????????:By exploring decentralized production models, the FDA aims to enhance patient access and streamline the delivery of personalized therapies. ???????????????? ????????????????????: Collaboration with industry leaders ensures that regulations keep pace with the rapid advancements in therapy development. Let’s continue to drive innovation and improve patient outcomes together! ??? Read more:https://bit.ly/4hR7eC7 #GenScriptBiotechGlobalForum #Biotech #GeneTherapy #CellTherapy #FDA #Innovation #PatientCare
-
-
?? ????????????/???????? is revolutionizing the treatment of Alzheimer's and Parkinson's diseases by targeting genetic mutations. Discover how it corrects mutations in genes like APP, PSEN1, PSEN2, and APOE4 in AD, and SNCA in PD, offering hope for future therapies! ?? Accelerate Gene Editing Breakthroughs with Genscript's Integrated CRISPR/Cas Protein Solutions! ?????????? ????????:https://bit.ly/4gUnrVL #CRISPR #GeneEditing #Alzheimers #Parkinsons #Biotech #ResearchApplications #GenScript #ScientificDiscovery
-
-
We're thrilled to team up with Multiply Labs in an innovative collaboration to automate cell isolation in cell therapy manufacturing using our scalable, customizable, cGMP and 21 CFR Part 11 compliant CytoSinct? platform. Together, we’re shaping the future of precision cell therapy. Stay tuned as we continue to push the limits of innovation! Learn more about ???????????????????: https://lnkd.in/eX77aiEw #GenScript #CytoSinct #MultiplyLabs #Biotech #BiotechInnovation #Podcast #Robotics #Automation
What do engineers often get wrong about science? And what do scientists often misunderstand about engineering? ?? The first episode of our podcast, Cell Mates, is here! ?? In this debut episode, we brought together Fred (Federico) Parietti, PhD, robotics engineer and CEO of Multiply Labs, and Sanket Acharya, PhD, scientist and senior director of corporate development at GenScript, to explore how these two worlds collide—and come together—to shape the future of pharma manufacturing. ?? It’s not just a conversation; it’s a deep dive into collaboration, innovation, and the power of bridging disciplines! Our mission is to bring science and engineering together to build the future of pharma manufacturing, one conversation at a time! Listen to the full episode on ?? YouTube: https://lnkd.in/g78W699S ?? Spotify: https://lnkd.in/gbgvNagr ?? Apple Podcasts: https://lnkd.in/gm84Grab ?? Amazon Music: https://lnkd.in/gEeRiWJy #CellMatesPodcast #Pharma #Automation #CellTherapy #AI #Robotics #PodcastLaunch
Cell Mates Podcast - Where Science & Engineering Collide in Pharma Automation
-
???????????????? ????????????????????: ???????????????? ???? ?????????????? ???????? ?????????????? We are dedicated to advancing your research and development journey. By sharing key insights into the latest trends and innovations, we aim to empower your therapeutic projects and help you navigate the ever-evolving landscape with confidence. ??Explore More:https://bit.ly/41fu3cW #CGTs #Immunotherapy #AdvancedTherapies #PrecisionMedicine #CancerResearch #InfectiousDiseases #Oncology #NeoantigenPeptide #Geneediting #mRNA #GMP #Clinical
-